Want to join the conversation?
$OTEX said the solutions being acquired from $HPQ are expected to generate $110-125MM of annualized revenues. The solutions will add immediately to $OTEX's earnings and on $OTEX operating model by end of 1Q17. The transaction is expected to close in 1Q17.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.